These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24820071)

  • 1. Cyclin D1 expression in prostate carcinoma.
    Pereira RA; Ravinal RC; Costa RS; Lima MS; Tucci S; Muglia VF; Reis RB; Silva GE
    Braz J Med Biol Res; 2014 Jun; 47(6):515-21. PubMed ID: 24820071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.
    Yu CC; Lin VC; Huang CY; Liu CC; Wang JS; Wu TT; Pu YS; Huang CH; Huang CN; Huang SP; Bao BY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S492-9. PubMed ID: 23354566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.
    Tsai H; Morais CL; Alshalalfa M; Tan HL; Haddad Z; Hicks J; Gupta N; Epstein JI; Netto GJ; Isaacs WB; Luo J; Mehra R; Vessella RL; Karnes RJ; Schaeffer EM; Davicioni E; De Marzo AM; Lotan TL
    Clin Cancer Res; 2015 Dec; 21(24):5619-29. PubMed ID: 26246306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
    Aaltomaa S; Kärjä V; Lipponen P; Isotalo T; Kankkunen JP; Talja M; Mokka R
    Anticancer Res; 2006; 26(6C):4873-8. PubMed ID: 17214354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
    Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
    Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancer.
    Vlachostergios PJ; Karasavvidou F; Patrikidou A; Voutsadakis IA; Kakkas G; Moutzouris G; Zintzaras E; Daliani DD; Melekos MD; Papandreou CN
    Pathol Oncol Res; 2012 Apr; 18(2):245-52. PubMed ID: 21786090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of differential cyclin D1 expression and localisation in prostate cancer.
    Comstock CE; Revelo MP; Buncher CR; Knudsen KE
    Br J Cancer; 2007 Mar; 96(6):970-9. PubMed ID: 17375037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy.
    Minner S; Hager D; Steurer S; Höflmayer D; Tsourlakis MC; Möller-Koop C; Clauditz TS; Hube-Magg C; Luebke AM; Simon R; Sauter G; Göbel C; Weidemann S; Lebok P; Dum D; Fraune C; Izbicki J; Burandt E; Schlomm T; Huland H; Heinzer H; Haese A; Graefen M; Heumann A
    Neoplasia; 2019 Sep; 21(9):872-881. PubMed ID: 31382165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6-A Study on 320 Patients After Radical Prostatectomy.
    Dolejsova O; Kucera R; Fuchsova R; Topolcan O; Svobodova H; Hes O; Eret V; Pecen L; Hora M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818787377. PubMed ID: 30021484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions.
    Ahmed ES; Elnour LS; Hassan R; Siddig EE; Chacko ME; Ali ET; Mohamed MA; Munir A; Muneer MS; Mohamed NS; Edris AMM
    BMC Res Notes; 2020 Jun; 13(1):295. PubMed ID: 32552908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.
    Drobnjak M; Osman I; Scher HI; Fazzari M; Cordon-Cardo C
    Clin Cancer Res; 2000 May; 6(5):1891-5. PubMed ID: 10815912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
    de la Taille A; Rubin MA; Bagiella E; Olsson CA; Buttyan R; Burchardt T; Knight C; O'Toole KM; Katz AE
    J Urol; 1999 Jul; 162(1):103-6. PubMed ID: 10379750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer.
    Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
    Am J Surg Pathol; 2002 Apr; 26(4):431-9. PubMed ID: 11914620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN; Roemeling S; Kranse R; Schröder FH; van der Kwast TH
    Eur Urol; 2007 Apr; 51(4):931-9. PubMed ID: 16935413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase cytogenetic study of preoperative core biopsies for the prediction of early serum prostate specific antigen recurrence after radical prostatectomy of clinically localized prostate carcinoma.
    Henke RP; Hammerer P; Graefen M; Erbersdobler A; Neumann M; Berger J; Huland H
    Cancer; 1998 Sep; 83(5):977-88. PubMed ID: 9731903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.